Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against HealthEquity, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is HealthEquity, Inc. (HQY) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HealthEquity, Inc. (“HealthEquity” or “the Company”) (NASDAQ: HQY). Investors who purchased HealthEquity securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether HealthEquity has violated federal securities laws.
What Potential Securities Violations Is BG&G Investigating?
On March 18, 2025, HealthEquity issued a press release announcing its financial results for its fourth quarter and fiscal year ended January 31, 2025. Among other items, HealthEquity reported fourth-quarter earnings per share that missed analyst expectations, while providing weak guidance for its fiscal year ending January 31, 2025. On a related earnings call, HealthEquity’s officers said that the Company had incurred “excess service expense” as a result of “increased cyber threats and fraud attacks from bad actors using sophisticated technology, techniques and methods.” On this news, HealthEquity’s stock price fell $17.35 per share, or 17.07%, to close at $84.32 per share on March 19, 2025.
What’s Next?
If you are aware of any facts relating to this investigation or purchased HealthEquity securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
How Did HealthEquity, Inc. (HQY) Stock React?
How Does BG&G Help Investors in Securities Fraud Investigations?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”